학술논문

Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis
Document Type
article
Source
Multiple Sclerosis Journal. 26(3)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Brain Disorders
Neurosciences
Multiple Sclerosis
Neurodegenerative
Autoimmune Disease
2.1 Biological and endogenous factors
Aetiology
Neurological
Animals
Atrophy
Encephalomyelitis
Autoimmune
Experimental
Female
Gray Matter
Hydrogels
Magnetic Resonance Imaging
Mice
Mice
Inbred C57BL
Sensorimotor Cortex
Spinal Cord
Voxel-based morphometry
CLARITY
EAE
MS
neurodegeneration
axonal loss
Neurology & Neurosurgery
Clinical sciences
Biological psychology
Language
Abstract
BackgroundGray matter (GM) atrophy in brain is one of the best predictors of long-term disability in multiple sclerosis (MS), and recent findings have revealed that localized GM atrophy is associated with clinical disabilities. GM atrophy associated with each disability mapped to a distinct brain region, revealing a disability-specific atlas (DSA) of GM loss.ObjectiveTo uncover the mechanisms underlying the development of localized GM atrophy.MethodsWe used voxel-based morphometry (VBM) to evaluate localized GM atrophy and Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging-compatible Tissue-hYdrogel (CLARITY) to evaluate specific pathologies in mice with experimental autoimmune encephalomyelitis (EAE).ResultsWe observed extensive GM atrophy throughout the cerebral cortex, with additional foci in the thalamus and caudoputamen, in mice with EAE compared to normal controls. Next, we generated pathology-specific atlases (PSAs), voxelwise mappings of the correlation between specific pathologies and localized GM atrophy. Interestingly, axonal damage (end-bulbs and ovoids) in the spinal cord strongly correlated with GM atrophy in the sensorimotor cortex of the brain.ConclusionThe combination of VBM with CLARITY in EAE can localize GM atrophy in brain that is associated with a specific pathology in spinal cord, revealing a PSA of GM loss.